Biorithm, Singapore’s star, lands $3.5M from Adaptive and SEEDS Capital.
Singaporean medical technology company Biorithm has closed a $3.5M Series A funding round, which was co-led by Adaptive Capital Partners and SEEDS Capital, the investment division of Enterprise Singapore. The firm plans